This information is effective as of July 1, 2024, and applies to all commercial employer groups that are assigned to the Net Results formulary. All changes to this list are the result of a comprehensive review of relevant clinical information by the Prime Therapeutics National Pharmacy and Therapeutics Committee.
Individual Market (Direct Pay/Direct Pay Exchange) Formulary
This information is effective as of April 1, 2024 and applies to the individual market segment (Direct Pay and Direct Pay Exchange) of BCBSRI products assigned to the Net Results HIM-compliant formulary. These changes do not apply to the BlueCHiP for Medicare programs. Any changes to this list are the result of a comprehensive review of relevant clinical information by the Prime Therapeutics National Pharmacy and Therapeutics Committee, with consultation form the BCBSRI Pharmacy and Therapeutics Committee.